Tonix Pharmaceuticals’ Acquisition of Preclinical Infectious Disease Portfolio from Healion Bio

Lowenstein represented Tonix Pharmaceuticals Holding Corp. in the transaction.Tonix Pharmaceuticals Holding Corp. (Nasdaq: TNXP) signed an agreement to acquire assets of Healion Bio, Inc., including its entire…

This content is for Standard 1 Year members only.
Login Join Now
Laura Testa

Author: Laura Testa

This content is for Standard 1 Year members only.
Login Join Now